Evoke Pharma Inc (EVOK)
4.50
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 12:46
Evoke Pharma Price to Book Value: 1.524 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.524 |
| November 20, 2024 | 1.545 |
| November 19, 2024 | 1.592 |
| November 18, 2024 | 1.480 |
| November 15, 2024 | 1.551 |
| November 14, 2024 | 1.479 |
| November 13, 2024 | 1.443 |
| November 12, 2024 | 1.694 |
| November 11, 2024 | 1.822 |
| November 08, 2024 | 1.914 |
| November 07, 2024 | 1.915 |
| November 06, 2024 | 1.978 |
| November 05, 2024 | 1.181 |
| November 04, 2024 | 1.167 |
| November 01, 2024 | 1.183 |
| October 31, 2024 | 1.193 |
| October 30, 2024 | 1.316 |
| October 29, 2024 | 1.285 |
| October 28, 2024 | 1.444 |
| October 25, 2024 | 1.081 |
| October 24, 2024 | 1.046 |
| October 23, 2024 | 1.046 |
| October 22, 2024 | 1.101 |
| October 21, 2024 | 1.118 |
| October 18, 2024 | 1.124 |
| Date | Value |
|---|---|
| October 17, 2024 | 1.088 |
| October 16, 2024 | 1.048 |
| October 15, 2024 | 1.042 |
| October 14, 2024 | 1.038 |
| October 11, 2024 | 1.059 |
| October 10, 2024 | 1.085 |
| October 09, 2024 | 1.054 |
| October 08, 2024 | 1.136 |
| October 07, 2024 | 1.097 |
| October 04, 2024 | 1.071 |
| October 03, 2024 | 1.061 |
| October 02, 2024 | 1.010 |
| October 01, 2024 | 0.9933 |
| September 30, 2024 | 0.9708 |
| September 27, 2024 | 1.479 |
| September 26, 2024 | 1.562 |
| September 25, 2024 | 1.476 |
| September 24, 2024 | 1.537 |
| September 23, 2024 | 1.617 |
| September 20, 2024 | 1.386 |
| September 19, 2024 | 1.365 |
| September 18, 2024 | 1.304 |
| September 17, 2024 | 1.340 |
| September 16, 2024 | 1.298 |
| September 13, 2024 | 1.325 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8685
Minimum
Nov 22 2022
32.12
Maximum
Jun 22 2020
5.132
Average
4.825
Median
Price to Book Value Benchmarks
| Repligen Corp | 3.981 |
| Eli Lilly and Co | 49.99 |
| MEI Pharma Inc | 0.7499 |
| Revance Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 3.184 |
Price to Book Value Related Metrics
| PS Ratio | 0.496 |
| Price | 4.50 |
| Earnings Yield | -245.1% |
| Market Cap | 6.687M |